Published in Hepatitis Weekly, January 15th, 2001
The HFE gene, now known to determine hereditary hemochromatosis, was studied by researchers for its potential as a factor in primary and secondary hemochromatosis in cirrhosis patients. Investigators sought mutations (C282Y) on this gene in hepatitis C cirrhosis patients and cryptogenic cirrhosis patients to see if there would be a correlation with increased iron deposition.
Only three of 26 and one of 22 hepatitis C and cryptogenic cirrhosis patients, respectively, were found to have the mutation, according to P. Lal,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.